Experienced in CLN1 Disease

Michael M. Jones

800 Blackburn Road, 
Clayton, VIC, AU 
Experienced in CLN1 Disease
800 Blackburn Road, 
Clayton, VIC, AU 
OverviewLocationsClinical Research

Overview

Michael Jones practices in Clayton, Australia. Mr. Jones is rated as an Experienced expert by MediFind in the treatment of CLN1 Disease. His top areas of expertise are Batten Disease, Retinoblastoma, CLN3 Disease, and CLN5 Disease.

His clinical research consists of co-authoring 34 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of CLN1 Disease.

Gender
Male

Locations

800 Blackburn Road, Clayton, VIC 3168, Australia
Other Locations
60 Musk Ave/Cnr. Blamey St, Kelvin Grove, QLD 4059, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

DASL-HiCaP: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801): A Randomised Phase 3 Double-blind, Placebo-controlled Trial of Adding Darolutamide to Androgen Deprivation Therapy and Definitive or Salvage Radiation in Very High Risk, Clinically Localised Prostate Cancer
DASL-HiCaP: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801): A Randomised Phase 3 Double-blind, Placebo-controlled Trial of Adding Darolutamide to Androgen Deprivation Therapy and Definitive or Salvage Radiation in Very High Risk, Clinically Localised Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2023
Intervention Type: Radiation, Drug
Study Drugs: Darolutamide, Luteinizing Hormone-Releasing Hormone Analog
Study Phase: Phase 3

34 Total Publications

Visual Recovery and Neurological Stabilization Following Miglustat Treatment in Pediatric CLN3 Disease.
Visual Recovery and Neurological Stabilization Following Miglustat Treatment in Pediatric CLN3 Disease.
Journal: Journal of child neurology
Published: September 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Jones's expertise for a condition
ConditionClose
        View All 10 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile